| AE | Adverse event |
| ARK5 | AMPK-related protein kinase 5 |
| ARDS | Acute respiratory distress syndrome |
| ATP | Adenosine triphosphate |
| BID | Twice daily |
| BSG | British Society of Gastroenterology |
| CD | Crohn’s disease |
| COVID-19 | Coronavirus disease 2019 |
| ECCO | European Crohn’s and Colitis Organization |
| EMA | European Medicines Agency |
| FDA | Food and Drug Administration |
| GI | Gastrointestinal |
| HDL | High density lipoprotein |
| IBD | Inflammatory bowel disease |
| IFN | Interferon |
| IOIBD | International Organization for the Study of Inflammatory Bowel Diseases |
| JAK | Janus kinase |
| LDL | Low-density lipoprotein |
| OD | Once daily |
| RA | Rheumatoid arthritis |
| RCT | Randomized controlled trial |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| STATs | Signal transducers and activators of transcription |
| TNF-α | Tumor necrosis factor α |
| TYK2 | Tyrosine kinase 2 |
| UC | Ulcerative colitis |